(Q80165547)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Tsutomu Nishida

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

C Matsuda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

T Ito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

T Mizushima

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

H Tamagawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Y Kai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Y Hamanaka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

M Inoue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

H Matsuda

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Y Sawa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

348-359

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17437423%20AND%20SRC:MED&resulttype=core&format=json

Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy

29 December 2019

cites work

1 reference

12 December 2020

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

1 reference

12 December 2020

Immunosuppressive drugs: the first 50 years and a glance forward

1 reference

12 December 2020

Applications of tacrolimus for the treatment of skin disorders

1 reference

12 December 2020

Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics

1 reference

12 December 2020

mTOR inhibitors: an overview

1 reference

12 December 2020

Control of intestinal inflammation by regulatory T cells

1 reference

12 December 2020

The evolving role of tor inhibitors for individualizing posttransplant immunosuppression

1 reference

12 December 2020

1 reference

12 December 2020

Review article: medical treatment of active Crohn's disease

1 reference

12 December 2020

Review article: the management of refractory Crohn's disease

1 reference

12 December 2020

Review article: Crohn's disease--the role of nutritional therapy

1 reference

12 December 2020

Rapid development of colitis in NSAID-treated IL-10-deficient mice.

1 reference

12 December 2020

Development and validation of a novel IL-10 deficient cell transfer model for colitis

1 reference

12 December 2020

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

1 reference

12 December 2020

Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients

1 reference

12 December 2020

Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients

1 reference

12 December 2020

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

1 reference

12 December 2020

Review of the proliferation inhibitor everolimus

1 reference

12 December 2020

Infliximab in the treatment of Crohn's disease: a user's guide for clinicians

1 reference

12 December 2020

Natalizumab for active Crohn's disease

1 reference

12 December 2020

Anti-interleukin-6 therapy for Crohn's disease

1 reference

12 December 2020

Granulocytapheresis for Crohn's disease: a report on seven refractory patients

1 reference

12 December 2020

Technology evaluation: MRA, Chugai

1 reference

12 December 2020

Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells

1 reference

12 December 2020

Clinical pharmacokinetics of everolimus

1 reference

12 December 2020

Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function

1 reference

12 December 2020

Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis

1 reference

12 December 2020

Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin

1 reference

12 December 2020

Cyclosporine treatment of inflammatory bowel disease

1 reference

12 December 2020

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

12 December 2020

Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology.

1 reference

12 December 2020

Cyclosporine therapy for inflammatory bowel disease: definitive answers and remaining questions

1 reference

12 December 2020

rho-Mediated protein tyrosine phosphorylation in lysophosphatidic-acid-induced tumor-cell invasion

1 reference

12 December 2020

A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.

1 reference

12 December 2020

gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses

1 reference

12 December 2020

T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.

1 reference

12 December 2020

Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506)

1 reference

12 December 2020

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

1 reference

12 December 2020

Tacrolimus (FK-506) treatment of fulminant colitis in a child

1 reference

12 December 2020

Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells

1 reference

12 December 2020

Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.

1 reference

12 December 2020

Studies with IL-10-/- mice: an overview.

1 reference

12 December 2020

CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice

1 reference

12 December 2020

Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine

1 reference

12 December 2020

IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice

1 reference

12 December 2020

Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).

1 reference

12 December 2020

Effector and regulatory lymphoid cells and cytokines in mucosal sites.

1 reference

12 December 2020

Administration of mAb against alpha E beta 7 prevents and ameliorates immunization-induced colitis in IL-2-/- mice

1 reference

12 December 2020

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

1 reference

12 December 2020

Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice

1 reference

12 December 2020

The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders

1 reference

12 December 2020